Carprieve 50 mg Tablets for Dogs

Kraj: Irlandia

Język: angielski

Źródło: HPRA (Health Products Regulatory Authority)

Składnik aktywny:

Carprofen

Dostępny od:

Norbrook Laboratories Limited

Kod ATC:

QM01AE91

INN (International Nazwa):

Carprofen

Dawkowanie:

50 mg/tablet

Forma farmaceutyczna:

Tablet

Typ recepty:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupa terapeutyczna:

Dogs

Dziedzina terapeutyczna:

carprofen

Wskazania:

N.S.A.I.D.

Status autoryzacji:

Authorised

Data autoryzacji:

2003-07-25

Charakterystyka produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprieve 50 mg Tablets for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
_ACTIVE SUBSTANCE:_
Carprofen
50 mg
_EXCIPIENTS:_
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablets:
A white/off white circular tablet with a break line on one face and
"50" scored on the opposing face.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For analgesia and reduction of chronic inflammation in musculoskeletal
disturbances in dogs, for example in
degenerative joint disease.
4.3 CONTRAINDICATIONS
Use of this product in cats is contra-indicated.
Do not use in dogs suffering from cardiac, hepatic or renal disease,
where there is a possibility of gastrointestinal
ulceration or bleeding, or where there is evidence of a blood
dyscrasia or hypersensitivity to the product.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to statements under Sections 4.3 and 4.5
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_1_
_1_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_9_
_4_
_7_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
Use in dogs less than 6 weeks of age, or in aged animals, may involve
additional risk.
If such use cannot be avoided,
such dogs may require a reduced dosage and carefu